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Abstract
Tbx1 is a T-box transcription factor implicated in DiGeorge syndrome. The molecular function of Tbx1 is unclear although it
can transactivate reporters with T-box binding elements. We discovered that Tbx1 binds Smad1 and suppresses the Bmp4/
Smad1 signaling. Tbx1 interferes with Smad1 to Smad4 binding, and a mutation of Tbx1 that abolishes transactivation, does
not affect Smad1 binding nor does affect the ability to suppress Smad1 activity. In addition, a disease-associated mutation
of TBX1 that does not prevent transactivation, prevents the TBX1-SMAD1 interaction. Expression of Tbx1 in transgenic mice
generates phenotypes similar to those associated with loss of a Bmp receptor. One phenotype could be rescued by
transgenic Smad1 expression. Our data indicate that Tbx1 interferes with Bmp/Smad1 signaling and provide strong
evidence that a T-box transcription factor has functions unrelated to transactivation.
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Introduction
Tbx1 is a T-box transcription factor required for pharyngeal
and cardiovascular development of humans and mice [1–3].
Mutations in TBX1 cause DiGeorge syndrome [4–6] and its
molecular functions are unknown, but it can transactivate
reporters with T-box binding elements [6–8]. T-box proteins,
including those of the Tbx1 subfamily may interact with histone
modifying enzymes H3K27-demethylase and H3K4-methyltrans-
ferase and thus modulate gene expression [9]. We and others have
identified a number of genes potentially targeted by Tbx1 [7,10–
13], but the mechanism(s) by which it can regulate the
transcription of these genes and how it controls developmental
pathways is unclear. A major obstacle to understanding these
mechanisms is our poor knowledge of the molecular interactors of
Tbx1. One of the best studied developmental functions of Tbx1 is
in heart development, where it is required to sustain proliferation
of mesodermally-derived cardiac progenitors of the second heart
field (SHF), a cardiac progenitor cell population that contributes to
the development of most of the heart, including the outflow tract
and right ventricle [7,14]. Recent data have shown that loss of
function of Tbx1 is associated with increased expression of
differentiation markers of the myocardium, suggesting that Tbx1
may also regulate negatively cardiomyocyte differentiation [13].
The mechanisms and gene networks that regulate the homeostasis
of the SHF cell population are not completely understood.
However, it is clear that major signaling systems, such as the
fibroblast growth factor (FGF) and bone morphogenetic protein
(BMP), as well as transcription factors such Nkx2.5, Isl1, Tbx1 and
Foxh1 contribute to specification, proliferation and/or mainte-
nance of this population [15]. In particular, it has been shown that
Nkx2.5 regulates negatively the expression of Bmp2, establishing
an Nkx2.5/Bmp2/Smad1 negative feedback loop that regulates
proliferation of cardiac progenitors of the SHF [16]. Here we show
that Tbx1 contributes to this network in an unexpected manner,
i.e. by binding to Smad1, interfering with Smad1-Smad4
dimerization and suppressing its transactivation ability.
Results
Tbx1 binds Smad1
To identify Tbx1 interacting proteins in mammalian cells, we
performed affinity purification of Tbx1-interactors complexes
followed by identification of co-purified proteins. To this end, we
assembled a mammalian expression vector (referred to as P19-
Tbx1-PA) coding for a fusion protein consisting of Tbx1 fused to
protein A (PA) via a tobacco etch virus (TEV) protease cutting site
(Figure 1a). We then generated stably transfected P19Cl6 cell lines
expressing the Tbx1-PA fusion protein as well as a control protein
without Tbx1 (P19-PA, Figure 1b). We selected P19CL6 cells
because they can differentiate into cardiomyocytes upon treatment
with DMSO [17] and, during this process, they express
endogenous Tbx1, most clearly after 4 days of treatment (Figure
S1). Thus, we treated P19-Tbx1-PA and P19-PA cell lines with
DMSO for 4 days, and then we obtained nuclear extracts, which
we subjected to affinity purification using IgG resin, and
proteolytic elution, using TEV protease, to recover Tbx1-
interacting protein complexes. Eluates were separated by SDS-
PAGE (Figure 1c) and processed for Western blotting analyses. We
tested antibodies against several candidate interactors, among
which anti phospho-Smad1/5/8, because of its relevance to
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e6049cardiovascular development and because of previous evidence of
interaction with other T-box proteins [18,19]. This antibody was
positive when tested against the affinity-purified material
(Figure 2a). Reciprocal coimmunoprecipitation of the two proteins
transiently expressed in NIH 3T3 cells confirmed the interaction
in mammalian cells (Figure 2b). We then extracted proteins from
E9.5 wild type (WT) embryos and carried out co-immunoprecip-
itation with an antibody against Tbx1. Western blot analysis after
immunoprecipitation revealed Smad1-specific immunoreactivity
in co-immunoprecipitated material (Figure 2c). The interaction
could not be demonstrated in cytosol extracts, indicating that it
occurs in the nucleus (Figure 2d). We next tested whether mutant
isoforms previously associated with a DiGeorge syndrome
phenotype are capable of binding Smad1. We found that the
mutant TBX1
F148Y (missense mutation in the T-box region [4])
can still bind Smad1, while the mutant TBX1
G310S (missense
mutation in a conserved region downstream to the T-box region
[4]) cannot (Figure 2e). In addition, we tested a T-box mutant
(TBX1
G145R), which has been shown to prevent DNA binding
[20]. Also this isoform interacted with Smad1 (Figure 2e). Overall,
these data suggest that the critical region for this interaction resides
downstream to and outside the T-box region. We next tested
whether Tbx1 could co-immunoprecipitated with other Smad
proteins. We found that P-Smad2, Smad4, Smad5, and Smad6 do
not interact with Tbx1 (Figure S2).
Tbx1 modulates negatively the Bmp4- Smad1 signal
transduction
To determine whether the interaction between Tbx1 and
Smad1 has functional consequences, we overexpressed Tbx1 and
assessed the transactivation ability of Smad1. We carried out a
luciferase assay in Cos-7 and C2C12 cells with the Smad-
responsive reporter NTK-tetramer-luc, which contains four copies
of a Smad consensus-binding element [21]. The reporter was
activated by transfection of a SMAD1 expression vector in Cos7
cells or by adding BMP4 to the culture media of C2C12 cells
(Figure 2f and Figure S3, respectively). In both cases we observed
that increasing amounts of transiently transfected TBX1 is capable
of suppressing Smad1- or BMP4-induced activation of the reporter
(Figure 2f and Figure S3a). TBX1 expression did not affect the
level of P-Smad1/5/8, Smad1 or the inhibitory Smad6 (Figure
S4). To assess the role of transcriptional activity for the Bmp-Smad
suppression activity, we expressed a mutant isoform of TBX1
(G145R) that carries a T-box mutation, which prevents DNA
binding [20]. As shown in Fig. 3a, TBX1
G145R was unable to
transactivate a T-box reporter, but it was still able to bind Smad1
Figure 1. Identification of Tbx1 interactors using affinity purification. Mouse P19-Cl6 embryonic carcinoma cells were stably transfected
with plasmid expressing TEV-protein-A alone or C-terminally fused to Tbx1 and induced to differentiate with 1% DMSO. a) Constructs used to
generate stably transfected P19CL6 cell clones. b) Western blot analysis of P19-Tbx1-PA and P19-PA (control) cell extracts. Proteins were separatedb y
gel electrophoresis on 10% SDS-PAGE gel and immunoblotted with human IgG F(c), which recognize protein A. c) Colloidal coomassie-stained 10%
SDS-PAGE gel containing nuclear extracts from P19-Tbx1-PA (lane 1) and P19-PA (lane 3) cells affinity purified by binding to IgG-Sepharose and then
enzymatically eluted by cleavage with TEV protease. Compared with non-purified nuclear extract from Tbx1-TEV-PA cells (lane 2).
doi:10.1371/journal.pone.0006049.g001
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PLoS ONE | www.plosone.org 2 June 2009 | Volume 4 | Issue 6 | e6049Figure 2. Tbx1 interacts with Smad1. a) Western blot analysis of affinity-purified nuclear extracts from P19-Tbx1-PA (lane 1) and P19-PA (lane 3)
cells, compared non-purified nuclear extracts of P19-Tbx1-PA cells (lane 2), using an antibody anti-Phospho-SMAD1/5/8. b) Western blot analyses of
reciprocal coimmunoprecipitation (IP) experiments using the antibodies indicated. NIH3T3 cells were co-transfected transiently with Tbx1-cmyc and
Smad1-Flag expression vectors. c) Western blot analyses of nuclear extracts from wild type E9.5 mouse embryos immunoprecipitated with an anti-
Tbx1 antibody (lanes 1 and 2) or with anti-rabbit IgG (lane 3) and revealed with an anti-SMAD1 antibody (lane 1 and 3) and an anti-Phospho-SMAD1/
5/8 antibody (lane 2). d) Immunoblotting with anti-Smad1 antibody of nuclear extracts of wild type mouse embryos (E9.5) coimmunoprecipitated
with anti-Tbx1 (NE-IP), total nuclear extracts (NE), total cytoplasmic extracts (CE), and cytoplasmic extracts coimminoprecipitated with anti-Tbx1 (CE-
IP). e) Coimmunoprecipitation of WT TBX1, TBX1
G145R, TBX1
F148Y, TBX1
G310S and Flag-SMAD1 transiently transfected in NIH 3T3 cells. The TBX1
G145R
and TBX1
F148Y mutants physically interact with Smad1, while TBX1
G310S is unable to bind Smad1 indicating that Glycine 310 is important for this
interaction. f) Luciferase assay using Cos7 cells transfected with the SMAD-responsive reporter NTK-tetramer-luc. Transfected SMAD1 activates the
reporter while increasing amounts (5 to 100 ng) of co-transfected TBX1 suppresses it.
doi:10.1371/journal.pone.0006049.g002
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assay, indicating that the anti-Smad activity of TBX1 is
independent from transcriptional activity. We obtained the same
results by activating the Smad reporter with BMP4 (Figure S3b).
Tbx1 interferes with Smad1-Smad4 binding
The Bmp-Smad1 signal transduction pathway requires binding
of phosphorylated Smad1 to Smad4 to transactivate target genes
[22]. To address the mechanism by which TBX1 suppresses Bmp-
Smad signal transduction, we tested whether TBX1 interferes with
SMAD1 to SMAD4 binding. To this end, we transfected SMAD1
(tagged with flag) with or without increasing amounts of TBX1 into
BMP4-treated C2C12 cells and carried out co-immunoprecipita-
tion of nuclear extracts using an anti-flag antibody. Western blot
analysis of immunoprecipitated material using an anti-Smad4
antibody revealed, in the absence of transfected TBX1, the
presence of Smad4, which was strongly reduced in samples co-
transfected with TBX1. This effect was dosage-dependent
(Figure 3c). In the same samples, the presence of TBX1 did not
affect the level of Smad1, and did not affect the level of Smad4 in
protein extracts before immunoprecipitation (Figure 3c). These
data suggest that TBX1 inhibits the Bmp-Smad signaling pathway
by interfering with Smad1-Smad4 interaction.
Transgenic expression of Tbx1 in mice mimics the
Bmpr1a loss of function phenotype
If TBX1 has an inhibitory effect on the Bmp-Smad1 pathway,
then ectopic expression of Tbx1 during mouse development may
mimic loss of function phenotypes associated with loss of Bmp-
Smad1 in the same tissues. To test the ability of Tbx1 to suppress
Smad1 signaling during mouse development, we have used a
mouse transgenic line, named COET (for Conditional OverEx-
pression of Tbx1), expressing Tbx1 upon Cre-mediated recombi-
nation [23]. We selected to cross this transgenic line with the
Ap2a
IREScre/+ driver [24] that expresses Cre in the ectoderm and
neural crest tissues, both of which require Bmp-Smad1 signaling.
Indeed, ectodermic deletion of the Bmp receptor gene Bmpr1a
caused cleft lip [25], and conditional ablation of the same gene in
neural crest cells caused cardiac outflow tract defects [26].
Ap2a
IREScre/+; COET animals did not survive after birth (data
not shown) and examination of E18.5 embryos revealed bilateral
cleft lip (Figure 4a–a’) and cardiac outflow tract (OFT) defects
(Figure 4b–b’) in all animals examined (n.20), and control
animals exhibited a normal phenotype (Figure 4a and b, and data
not shown). Moreover, consistent with the hypothesis of a
suppression of the Bmp-Smad1 pathway, we observed reduced
expression of the Bmp-Smad1 target gene Msx1 [27] in E9.5 and
E10.5 Ap2a
IREScre/+;COET embryos (Figure 4c-f’).
Transgenic expression of Smad1 rescues partially the
Tbx1 over expression phenotype
If the Ap2a
IREScre/+;COET associated phenotype is due to
functional depletion of Smad1, then providing an additional
source of Smad1 to the affected tissues may ameliorate the
phenotype. To test this idea, we generated a mouse transgenic line
that expresses SMAD1 upon Cre-induced recombination (Figure
S5). This transgenic line, named Fsmad1, was made with the same
procedure and construct used to generate the COET line, except
that we used a SMAD1 cDNA instead of the Tbx1 cDNA.
Ap2a
IREScre/+;Fsmad1 E18.5 embryos were grossly normal (data
not shown), suggesting that additional Smad1 expression in the
ectoderm and neural crest, where endogenous Smad1 is normally
expressed, did not cause any obvious developmental anomaly.
Next, we crossed COET;Fsmad1 mice with Ap2a
IREScre/+ mice
and examined the progeny at E18.5. No obvious abnormalities
were detected in Ap2a
IREScre/+;Fsmad1, but, as expected, all the
Ap2a
IREScre/+;COET examined (n=7) exhibited cleft lip and
cardiac outflow tract defects (similar to those shown in Figures 4a’
and b’, respectively). However, with one exception, none of the
Ap2a
IREScre/+;COET;Fsmad1 embryos examined exhibited cleft lip
(n=6, Figure 4g), however, they did exhibit outflow tract defects.
Thus, excess Smad1 expression was sufficient to rescue the cleft lip
phenotype of Ap2a
IREScre/+;COET embryos but not the heart
phenotype.
Discussion
This study identified Smad1 as a novel interactor for the Tbx1
protein, and the only one that has been validated with endogenous
proteins from embryos to date. Nowotschin et al. have shown that
Tbx1 and Nkx2.5 interact in cell cultures, although they have not
shown that the two endogenous proteins interact in embryo tissues
[28]. While we did not map the regions of interaction between
Tbx1 and Smad1, we demonstrate that a disease-associated
missense mutation of Tbx1 in the C-terminal region of the protein
is sufficient to prevent binding. These data suggest that
perturbance of the Tbx1-Smad1 interaction may be part of the
pathogenetic mechanism of DiGeorge syndrome.
Xbra, a Xenopus T-box protein, also binds to Smad1, and this
interactions appears necessary to prevent Xbra from activating
Goosecoid, but how exactly this is effected is unclear [18]. We show
that Tbx1 modulates negatively Smad1-dependent transactivation
by interfering with Smad1-Smad4 interaction. Using mouse
transgenic models we could reproduce in vivo the Tbx1-mediated
Smad1 repression. This could be revealed by the occurrence of a
phenotype similar to that caused by loss of Bmpr1a, and by reduced
expression of a BMP target, Msx1,i nAp2a
IREScre/+;COET
embryos. In these embryos, Msx1 expression appeared downreg-
ulated only in some tissues. This may be due to tissue-specific Cre
expression or to different, tissue specific mechanisms of Msx1
regulation. In any case, the phenotype of ectopic expression of
Tbx1 could be partially rescued by transgenic expression of Smad1
in the same tissues. The heart phenotype caused by ectopic
expression of Tbx1 in Ap2a
IREScre/+;COET embryos could not be
rescued by transgenic expression of Smad1. This could be because
Tbx1 ectopic expression in the neural crest may cause more
perturbances than simply BMP suppression, perhaps in early
development of neural crest cells destined to populate the heart.
Among the various developmental roles, Tbx1 is thought to
maintain proliferation of mesodermally-derived cardiac progeni-
tors of the second heart field (SHF) [14], a migratory cell
population that enters the heart in a relatively late stage of its
development [15]. Prall and coworkers [16] showed that Smad1
ablation in the SHF enhances cell proliferation, and thus it has
been proposed as a negative modulator of cardiac progenitors
proliferation. Thus, it is conceivable, that Tbx1, by repressing
Smad1, contributes to maintenance of cell proliferation. Recently
it has been shown that Chordin (Chrd), a BMP antagonist, is a
mild modifier of the Tbx1 mutant phenotype. Indeed, Choi and
Klingensmith [29] showed that loss of Chrd enhances the
craniofacial phenotype of Tbx1 mutants. This effect can be
interpreted on the basis of our findings, i.e. at least part of the Tbx1
mutant phenotype is due to excessive BMP signaling, thus
removing an antagonist of BMP in a Tbx1 mutant background
further enhances the excess of BMP. The heart phenotype was not
affected by Chrd mutation presumably because this gene is not
expressed in heart tissues.
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PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e6049Figure 3. Transactivation ability of Tbx1 is not required for Smad pathway suppression; Tbx1 interferes with Smad1/Smad4
binding. a) A luciferase assay showing the inability of the TBX1
G145R mutant to transactivate a T-box reporter construct in Jeg3 cells. Error bars
indicate the standard error mean. b) A luciferase assay with a SMAD reporter showing that the mutant is capable of suppressing SMAD
transactivation. c) Western blot analyses of nuclear extracts from C2C12 transfected with Tbx1 and SMAD1-flag expression vectors (as indicated). The
top two rows are samples immunoprecipitated with an anti-flag antibody. The bottom two rows are non-immunoprecipitated nuclear extracts from
the same samples. Note the strong reduction of Smad4 co-immunoprecipitated with Smad1 in the presence of transfected TBX1.
doi:10.1371/journal.pone.0006049.g003
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of the major signaling systems, i.e. the fibroblast growth factor
(FGF) signaling [7,10,30,31], the Retinoic acid signaling [12,31],
the Delta-Notch1 signaling [32] and the BMP/Smad1 signaling
(this work). Thus, we propose that Tbx1, by modulating positively
the FGF and negatively the BMP-Smad1 signaling systems plays a
central role in the homeostasis of cardiac progenitor cells of the
SHF.
Finally, and perhaps most surprisingly, we show that the Smad1
modulatory effect of Tbx1 is not dependent upon DNA binding,
therefore, this represents the first example of a transcription-
independent function of a T-box transcription factor.
Materials and Methods
Constructs and cell lines
To generate the FSMAD1 transgene construct, the Flag-
SMAD1 cDNA was excised from pCMV5-FlagSMAD1 [33]
and cloned 39 to a loxP-flanked neomycin resistance cassette with
3 polyadenylation-sites (the backbone plasmid is a kind gift from
Drs. A. Simeone and F. Tuorto, Institute of Genetics and
Biophysics, Naples). C2C12 cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% heat-inactivat-
ed fetal bovine serum. The human choriocarcinoma-derived
placental JEG3 cell line was maintained in Minimum Essential
Medium (SIGMA) supplemented with 10% fetal bovine serum.
P19CL6 cells were grown in Dulbecco-Modified Minimal
Essential Medium supplemented with 10% fetal bovine serum.
For differentiation of P19CL6 cells, the culture medium was
supplemented with 1% DMSO (Sigma-Aldrich). To generate
stably transfected cell lines, 10
7 P19CL6 cells were electroporated
with 10 mg of DNA of an expression vector containing the cmv
promoter driving a mouse Tbx1 cDNA fused with a TEV target
site and a Protein A coding cDNA (the plasmid backbone has been
described in ref. [34]. Using the same procedure but with an
expression vector encoding the TEV site, Protein A but not Tbx1,
we obtained a control cell line, P19-PA. Selection was performed
using G418 (200 mg/ml). Resistant clones were picked, expanded
and tested for expression of the transgenic proteins by western
blotting.
Nuclear/Cytoplasmic Extract Isolation
Cells were cultured in 10 cm dishes until 60–70% confluence
and transfected with Fugene6 (Roche) following the manufacturer
protocol. After 24–48 h after transfection, cells were washed,
scraped in cold PBS, and collected by centrifugation using a
refrigerated centrifuge at 1000 rpm for 10 min. The pellet was
resuspended in 5 pellet volumes of cold CE buffer (10 mM
HEPES, 60 mM KCl, 1 mM EDTA, 0.075% v/v NP40, 1 mM
DTT and 1X protease inhibitors, adjusted to pH 7.6), and
centrifuged at 1400 rpm for 4 min. The nuclei were washed with 5
pellet volumes of cold CE buffer without detergent and spinned as
above at 1400 rpm for 4 min. 2x pellet volume of NE buffer were
added to the nuclear pellet incubating on ice for 30 min. Nuclear
Figure 4. Ectopic expression of Tbx1 in mouse embryos
suppresses the Smad1 pathway in vivo. a–a’) A Ap2a
IRESCre/+;Coet
embryo (a’) at E18.5 shows bilateral cleft lip, compared with a control
littermate (a). b–b’) Three-dimensional reconstruction from digital
images of histological sections of E16.5 hearts from control (b) and
Ap2a
IRESCre/+;Coet embryos. The cavities of the right (RV) and left (LV)
ventricles, as well as the great arteries are shown in red. Note the large
ventricular septal defect (VSD), and the common origine of the aorta
and pulmonary arteries from the right ventricle, a condition known as
double outlet right ventricle (DORV). (c–f’) Whole-mount in situ
hybridization analysis of Msx1 expression in WT (c, d, e, f) and
Ap2a
IRESCre/+;Coet embryos (c’, d’, e’, f’) at E9.5 (c–d’) and E10.5 (e–f’).
Mutant embryos show reduced expression in the maxillary region
(white arrows) and in the second pharyngeal arch (black arrows). (g)
Cleft lip present in Ap2a
IRESCre/+;Coet embryos (compare with panel a) is
rescued by the FSMAD1 transgene.
doi:10.1371/journal.pone.0006049.g004
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for 30 min to pellet any nuclei.
Affinity purification
Native affinity purification was performed with strains P19-
Tbx1-PA and P19-PA as previously described [35]. Nuclear
extracts were transferred to Poly-Propylene Chromatography
Columns (10 ml volume; Pierce), which contained 2 ml of pre-
washed (with IPP150: 10 mM Tris-HCl, pH 8.0; 150 mM NaCl;
0.1% NP-40) IgG sepharose beads (Amersham). Columns were
sealed and slowly rotated for 2 h at 4uC. After three washes with
10 ml of IPP150 buffer and one wash with 10 ml of TEV cleavage
buffer (910 mM Tris-HCl, pH 8.0; 150 mM NaCl; 0.1% NP-40;
0.5 mM EDTA; 1 mM DTT), we added 1 ml TEV cleavage
buffer and 10 ml of TEV enzyme (Amersham). Protein eluates
were concentrated and loaded on a 10% SDS-acrylamide gel.
Proteins were stained with colloidal coomassie or transferred into
PVDF membrane (Amersham) for Western blotting analyses.
Co-Immunoprecipitation
For co-immunoprecipitation experiments, cells were lysed at
4uC in Nonidet P-40 lysis buffer. Extracts were quantified using a
modified Bradford procedure (Bio-Rad Laboratories, Hercules,
CA). Co-immunoprecipitation of TBX1 and Flag-SMAD1 was
accomplished using an antibody-coupling gel to precipitate the
bait protein and co-immunoprecipitate the interacting prey
protein. Anti-Tbx1 (Zymed Laboratories) or anti-Flag M2
antibody (SIGMA) was coupled to an amine-reactive gel
(ProFound co-immunoprecipitation kit, Pierce) using slow agita-
tion at 4uC O.N. The precipitated protein complexes were run on
a 10% SDS-acrylamide gel, and analysed by Western blotting.
Luciferase assay
Cos-7 cells were grown in 24-well plates and transfected with
100 ng of NTK-tetramer-luc vector [21], 100 ng of pCMV5-
FlagSMAD1 and 5 ng to 100 ng of h-TBX1 (a TBX1 expression
vector obtained by cloning a human cDNA into the CMV expression
plasmid pCDNA3). C2C12 cells were grown in 24-well plates,
transfected with 100 ng of NTK-tetramer-luc vector, 5 ng to 100 ng
of h-TBX1 and stimulated with 50 ng/ml of Human recombinant
BMP4. JEG3 cells were grown in 24-well plates and transfected using
Fugene-6 (Roche) with 100 ng of 2xTtkGL2 vector [6], 5 ng of b-
Gal-expressionvector,and100 ngofh-TBX1. Inalltheexperiments,
the total amount of transfected DNA was adjusted with empty vectors
so that all samples received the same amount. Light emission of
extracts was measured using a luminometer.
Mouse Mutants and Breedings
All the experiments involving mice were done according to a
protocol reviewed and approved by the Institutional Animal Care
and Use Committee of Institute of Biosciences and Technology, in
compliance with the USA Public Health Service Policy on
Humane Care and Use of Laboratory Animals.
The mutant AP2a
IREScre used in this study has been previously
reported [36]. The COET transgenic mouse line has been
described previously [23]. The FSMAD1 transgenic line was
generated as follows. The FSMAD1 construct (described above)
was linearized and electroporated into feeder-free E14Tg2A.4
embryonic stem cells (strain 129/Ola, BayGenomics). Cells were
selected with G418, and 96 resistant clones were screened by
southern blot using a probe specific for the Flag-SMAD1
sequence. 2 positive clones were tested for SMAD1 expression
with Western blotting analysis after Cre recombination. One of
the clones was injected into C57Bl6 blastocysts to obtain chimeric
mice. Founders were backcrossed into the C57/Bl6 strain and
maintained in a mixed genetic background C57/Bl6-129/Ola.
FSMAD1 transgenic mice were crossed with COET mice (same
genetic background) to generate COET; FSMAD1 mice for use in
timed matings. COET; FSMAD1 mice were crossed with
AP2a
IRESCre/+ animals to generate embryos of the appropriate
stage and genotype. The FSMAD1 transgene was genotyped with
the following primers: 1) 59- caaagacgacgatgacaagg -39 and 2) 59-
agctcaaggccttttccagt -39. Phenotypic analyses of mutant embryos
were carried out by gross morphological analyses, embryo
dissection and hystological analyses. In some cases, we used digital
images of 10 mm-thick histological sections to carry out three-
dimensional reconstructions using the software AMIRA 4.1.2
(Mercury Computer Systems).
In-situ hybridization
Whole mount in situ hybridization was performed by standard
methods. The mouse Msx1 probe was kindly provided by James F.
Martin (Institute of Biosciences and Technology, Houston).
Sources of antibodies and proteins
The anti-Tbx1 antibody was obtained from Zymed Laborato-
ries; the anti-P-Smad1 (Ser463/Ser465) from Chemicon; The anti
Smad1, P-Smad2 (Ser465/Ser467), Smad4, Smad5, and Smad6
where all purchased from Cell Signaling. Recombinant proteins
BMP4 and TGFb1 were obtained from R&D Systems.
Supporting Information
Figure S1 Endogenous Tbx1 expression during cardiomyocite
differentiation of P19Cl6 cells. RT-PCR analyses for the indicated
mRNAs were performed on differentiating P19Cl6 cells. The
Tbx1 amplification signal is more clearly evident starting from day
4 of differentiation.
Found at: doi:10.1371/journal.pone.0006049.s001 (1.71 MB TIF)
Figure S2 P-Smad2, Smad4, 5, and 6 do not interact with Tbx1.
Nuclear extracts of mouse P19-Cl6 cells induced to differentiate
with 1% DMSO were purified by binding to IgG-Sepharose,
digested with TEV protease and immunoblotted with (a) anti-
Smad5, (b) anti-Smad4 and (c) anti-Smad6 antibodies. Lane 1:
Purified nuclear extracts of cells expressing Tbx1-TEV-PA. Lane
2: Total nuclear extracts of cells expressing Tbx1-TEV-PA. Lane
3: Purified nuclear extracts of cells expressing TEV-PA alone. (d)
NIH-3T3 cells were transiently transfected with TBX1, stimulated
with 5 ng/ml of TGFb1 for 1 hour and protein extracts were
coimmunoprecipitated with anti-Tbx1 and immunoblotted with
anti-Phospho-Smad2 antibody.
Found at: doi:10.1371/journal.pone.0006049.s002 (8.51 MB TIF)
Figure S3 TBX1 or TBX1G415R are both capable of suppress-
ingaSmadreporterafterBMP4activation.a)Luciferaseassayusing
a Smad reporter (NTK-tetramer-luc) with C2C12 cells exposed to
BMP4. Increased amounts of TBX1 expression vector DNA (from
5 ng to 100 ng) is associated with reduced luciferase activity. b) In a
similar experiment, a vector encoding the mutant TBX1G145R
isoform, which cannot transactivate a T-box reporter, has a similar
capacity to suppress the Smad-reporter activity as the wild type
isoform. The mean data are representative of three replicates for
each condition and the error bars show the standard error.
Found at: doi:10.1371/journal.pone.0006049.s003 (8.81 MB TIF)
Figure S4 TBX1 does not affect the level of P-Smad1/5/8,
Smad1 and inhibitory Smad6. Western blot analyses of protein
extracts from BMP4-induced and non induced C2C12 cells, with
Tbx1 Regulates Smad1 Signaling
PLoS ONE | www.plosone.org 7 June 2009 | Volume 4 | Issue 6 | e6049or without TBX1 transfection. None of the immunoreactivities
tested in this figure is affected by TBX1 expression.
Found at: doi:10.1371/journal.pone.0006049.s004 (7.23 MB TIF)
Figure S5 Generation of the FSMAD1 transgenic line. a)
Schematic representation of the transgenic construct, which
includes a chicken b-actin promoter, a loxP-flanked promoterless
neo resistance cassette with 3 copies of a polyadenilation signal,
and a cDNA encoding human SMAD1 tagged at the N-terminal
with flag. b) Southern-blot of BamHI-digested DNA from ES-cell
clones (parental and transgenic) probed with a Flag-SMAD1-
specific probe. The position of the BamHI restriction sites is
indicated on panel a. c) Western-blot analysis of protein extracts
from parental and transgenic ES clones after transient Cre
recombinase expression, using an anti-Flag antibody. A transgenic
protein of the appropriate size is clearly evident in the transgenic
cell line. d) PCR analysis of DNA from transgenic embryos using
FSMAD1-specific the oligonucleotides 1) 59- caaagacgacgatga-
caagg -39 and 2) 59- agctcaaggccttttccagt -39(the position of
primers is schematically indicated on panel a.
Found at: doi:10.1371/journal.pone.0006049.s005 (4.93 MB TIF)
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